Abstract B057: Preclinical intracranial activity of NVL-330, a selective HER2 tyrosine kinase inhibitor
Year: 2025
Type: conference-abstract
Source: Molecular Cancer Therapeutics
Authors: Yuting Sun, Kristin L. Andrews, Anupong Tangpeerachaikul, Michael J. Walsh, Nancy E. Kohl, Joshua C. Horan, Henry E. Pelish
Institution: Nuvalent, Inc. (United States)
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4415444405
Cites:
Cited by:
Related to: